Clinical trial
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux…
NCT03214081 · Takeda, Industry · Completed
Key facts
| NCT number | NCT03214081 |
|---|---|
| Title | Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" |
| Official title | Special Drug Use Surveillance of Takecab Tablets for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Reflux Esophagitis |
| Intervention type | Drug |
| Interventions | Vonoprazan |
| Enrollment | 1,237 |
| Start date | Mar 1, 2016 |
| Primary completion | Aug 31, 2018 |
| Completion | Aug 31, 2018 |
| First posted | Jul 11, 2017 |
| Last update posted | Jun 10, 2025 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: